Patient-centered medicine and patient-oriented research: improving health outcomes for individual patients

BackgroundPatient-centered medicine is developing alongside the concepts of personalized medicine and tailored therapeutics. The main objective of patient-centered medicine is to improve health outcomes of individual patients in everyday clinical practice, taking into account the patient’s objectives, preferences, values as well as the available economic resources.DiscussionPatient-centered medicine implies a paradigm shift in the relationship between doctors and patients, but also requires the development of patient-oriented research. Patient-oriented research should not be based on the evaluation of medical interventions in the average patient, but on the identification of the best intervention for every individual patient, the study of heterogeneity and the assignment of greater value to observations and exceptions. The development of information-based technologies can help to close the gap between clinical research and clinical practice, a fundamental step for any advance in this field.SummaryEvidence-based medicine and patient centered medicine are not contradictory but complementary movements. It is not possible to practice patient-centered medicine that is not based on evidence, nor is it possible to practice evidence-based medicine at a distance from the individual patient.

[1]  D. Butler.  Translational research: Crossing the valley of death , 2008, Nature.

[2]  C. J. Wang,et al.  Integrating technology into health care: what will it take? , 2012, JAMA.

[3]  Sacristán Ja.  [Medicine-based evidence]. , 1999 .

[4]  S A Narod,et al.  Personalized medicine: a personal view. , 2010, Current oncology.

[5]  J. Sacristán,et al.  Exploratory trials, confirmatory observations: A new reasoning model in the era of patient-centered medicine , 2011, BMC medical research methodology.

[6]  R W Makuch,et al.  Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation. , 1996, Journal of clinical epidemiology.

[7]  R. Thomson,et al.  Decision aids for people facing health treatment or screening decisions. , 2003, The Cochrane database of systematic reviews.

[8]  J. Hampton,et al.  The end of clinical freedom. , 1983, Rivista dell'infermiere.

[9]  U. S. Department of Health and Human Services FDA Cen Research,et al.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance , 2006, Health and quality of life outcomes.

[10]  J A Sacristán.  [Medicine-based evidence]. , 1999, Medicina clinica.

[11]  J Soto,et al.  Randomized database studies: a new method to assess drugs' effectiveness? , 1998, Journal of clinical epidemiology.

[12]  Malcolm Rowland,et al.  Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response , 2011, Nature Reviews Drug Discovery.

[13]  J. A. Sacristán,et al.  Medicina centrada en el paciente e investigación de la efectividad comparada , 2011 .

[14]  J Lau,et al.  Uncontrolled pearls, controlled evidence, meta-analysis and the individual patient. , 1998, Journal of clinical epidemiology.

[15]  R Peto,et al.  Why do we need some large, simple randomized trials? , 1984, Statistics in medicine.

[16]  Liana Fraenkel,et al.  Individualized medical decision making: necessary, achievable, but not yet attainable. , 2010, Archives of internal medicine.

[17]  R Peto,et al.  Trials: the next 50 years , 1998, BMJ.

[18]  Kazem Rahimi,et al.  Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: systematic review , 2010, BMJ : British Medical Journal.

[19]  B Merz.  First anti-oncogene discovered; linked to the development of retinoblastoma. , 1987, JAMA.

[20]  Ewout W Steyerberg,et al.  Estimating treatment effects for individual patients based on the results of randomised clinical trials , 2011, BMJ : British Medical Journal.

[21]  Susan Dorr Goold,et al.  Patient-centered care and preference-sensitive decision making. , 2009, JAMA.

[22]  Manfred Hauben,et al.  Anecdotes that provide definitive evidence , 2006, BMJ : British Medical Journal.

[23]  Peter J Neumann,et al.  What we talk about when we talk about health care costs. , 2012, The New England journal of medicine.

[24]  Tatiana Dilla,et al.  Health economics: the start of clinical freedom , 2010, BMC health services research.

[25]  Murray Krahn,et al.  Incorporating Patient Preferences in Evidence-Based Medicine—Reply , 2008 .

[26]  M. Tinetti,et al.  Goal-oriented patient care--an alternative health outcomes paradigm. , 2012, The New England journal of medicine.

[27]  Martin Marshall,et al.  Supporting patients to make the best decisions , 2011, BMJ : British Medical Journal.

[28]  Fiona Godlee,et al.  Outcomes that matter to patients , 2012, BMJ : British Medical Journal.

[29]  D. Stryer,et al.  Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. , 2003, JAMA.

[30]  D A Bloch,et al.  Capturing the patient's view of change as a clinical outcome measure. , 1999, JAMA.

[31]  Grant D. Huang,et al.  Observational methods in comparative effectiveness research. , 2010, The American journal of medicine.

[32]  Milos Jenicek,et al.  Clinical Case Reporting in Evidence-based Medicine , 1999 .

[33]  Brian Salter,et al.  Patients and doctors: reformulating the UK health policy community? , 2003, Social science & medicine.

[34]  S. Satya‐Murti.  Evidence-based Medicine: How to Practice and Teach EBM , 1997 .

[35]  F. Davidoff,et al.  Patient-Centered Medicine: A Professional Evolution , 1996 .

[36]  D. Cella,et al.  Developing a Valid Patient‐Reported Outcome Measure , 2011, Clinical pharmacology and therapeutics.

[37]  Arno Vosk.  Evidence from randomized controlled trials, meta-analyses, and subgroup analyses. , 2010, JAMA.

[38]  J. Groopman,et al.  Keeping the patient in the equation--humanism and health care reform. , 2009, The New England journal of medicine.

[39]  Alvan Feinstein,et al.  Clinical Judgment Revisited: The Distraction of Quantitative Models , 1994, Annals of Internal Medicine.

[40]  B. Charlton,et al.  Individual case studies in clinical research. , 1998, Journal of evaluation in clinical practice.

[41]  J. A. Sacristan.  EVIDENCIA BASADA EN LA MEDICINA , 1999 .

[42]  D. Roden,et al.  The Emerging Role of Electronic Medical Records in Pharmacogenomics , 2011, Clinical pharmacology and therapeutics.

[43]  A. Stuebe,et al.  Level IV evidence--adverse anecdote and clinical practice. , 2011, The New England journal of medicine.

[44]  G. Simon,et al.  Choosing a first-line antidepressant: equal on average does not mean equal for everyone. , 2001, JAMA.

[45]  Jay Landers.  What Will It Take , 2014 .

[46]  Xavier Badia,et al.  A systematic review of patient-reported and economic outcomes: value to stakeholders in the decision-making process in patients with type 2 diabetes mellitus. , 2011, Clinical therapeutics.

[47]  Murray Krahn,et al.  The next step in guideline development: incorporating patient preferences. , 2008, JAMA.

[48]  Deborah Grady,et al.  Why is a good clinical prediction rule so hard to find? , 2011, Archives of internal medicine.

[49]  David Mant,et al.  Can randomised trials inform clinical decisions about individual patients? , 1999, The Lancet.

[50]  J. Sacristán,et al.  Evidence from randomized controlled trials, meta-analyses, and subgroup analyses. , 2010, JAMA.

[51]  Gordon H Guyatt,et al.  Patient-important outcomes in registered diabetes trials. , 2008, JAMA.

[52]  Richard L Kravitz,et al.  Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. , 2004, The Milbank quarterly.

[53]  Andrew D Oxman,et al.  Closing the gap between research and practice : an overview of systematic reviews of interventions to promote the implementation of research findings , 2011 .

[54]  Robert H. Brook,et al.  Can the Patient-Centered Outcomes Research Institute become relevant to controlling medical costs and improving value? , 2011, JAMA.

[55]  L. Burke,et al.  The Patient‐Reported Outcome (PRO) Consortium: Filling Measurement Gaps for PRO End Points to Support Labeling Claims , 2011, Clinical pharmacology and therapeutics.

[56]  Sarah Schmiege,et al.  Comparative Effectiveness Research , 2013, Western journal of nursing research.

[57]  M. Barry,et al.  Shared decision making--pinnacle of patient-centered care. , 2012, The New England journal of medicine.

[58]  William Godolphin,et al.  Shared decision-making. , 2009, Healthcare quarterly.

[59]  S. Greenfield,et al.  Comparative Effectiveness Research: A Report From the Institute of Medicine , 2009, Annals of Internal Medicine.

[60]  Peter Fayers,et al.  Can overall results of clinical trials be applied to all patients? , 1995, The Lancet.

[61]  C. Deangelis,et al.  Basic science and translational research in JAMA. , 2002, JAMA.

[62]  L J Lesko,et al.  What Is Clinical Utility and Why Should We Care? , 2010, Clinical pharmacology and therapeutics.

[63]  M. Rawlins.  De testimonio: on the evidence for decisions about the use of therapeutic interventions , 2008, The Lancet.

[64]  Wayne B. Jonas.  Scientific evidence and medical practice: The "Drunkard's Walk". , 2009, Archives of internal medicine.

[65]  Robert D Truog,et al.  Patients and doctors--evolution of a relationship. , 2012, The New England journal of medicine.

[66]  Xavier Badia,et al.  Which nontraditional outcomes should be measured in healthcare decision-making in schizophrenia? A systematic review. , 2012, Perspectives in psychiatric care.

[67]  Stephen W Lagakos,et al.  Statistics in medicine--reporting of subgroup analyses in clinical trials. , 2007, The New England journal of medicine.

[68]  B G Charlton.  Individual case studies in primary health care. , 1999, Family practice.

[69]  Bryan R Luce,et al.  Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change , 2009, Annals of Internal Medicine.

[70]  M. Porter.  A strategy for health care reform--toward a value-based system. , 2009, The New England journal of medicine.

[71]  S. Woolf.  The meaning of translational research and why it matters. , 2008, JAMA.

[72]  J. Vandenbroucke.  In Defense of Case Reports and Case Series , 2001, Annals of Internal Medicine.

[73]  David O Meltzer,et al.  The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. , 2006, Diabetes care.